logo

Search

Helicobacter Pylori Test Market By Type (Endoscopic and Non-Endoscopic), By Technology (Point-of-Care (POC), Immunoassays, and Molecular Diagnostics), By End User (Hospital & Clinics, Diagnostic Center, and Others), Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2020-2026.

Report ID : 2348 | Publisher ID : Meta | Published : 2023-09-27 | Pages : 251

Licence Type
$ 3550
$ 5350
$ 7100

Market Definition 

Helicobacter pylori is a bacteria that infect the digestive system. H. pylori can cause peptic ulcers. Helicobacter pylori tests help to detect a Helicobacter pylori infection in the stomach and upper part of the small intestine. Helicobacter pylori tests are done through endoscopic and non-endoscopic procedures. 

Global helicobacter pylori test market is estimated to reach $XX million by 2026; growing at a CAGR of 7.6% till 2026. 

Market Dynamics 

Rising prevalence of helicobacter pylori is a key driving factor of the market. Helicobacter pylori is the cause of peptic ulcers and can also cause gastritis and stomach cancer. H. pylori affect approximately 50% of the world's population. Around 30% to 40% of people in the United States get H. pylori infection. In the United States, the estimated prevalence is 20% for people younger than 30 years and 50% for people older than 60 years. H. pylori prevalence is higher in Hispanics, African Americans, and the elderly. H. pylori prevalence in Hispanics is 60%, more than 54% in African Americans, and 20% in whites. Further, the presence of poor sanitation, poor personal hygiene, contaminated water or food, and high dense population are the factors expecting the market growth over the period. However, lack of awareness regarding helicobacter pylori infection in underdeveloped countries might hamper market growth. Lack of knowledge regarding H. pylori bacterium modes of transmission, associated diseases, carcinogenic effect and means of prevention, and lack of awareness on the transmission routes of H. pylori infection. Moreover, growing demand for point of care testing devices for helicobacter pylori would provide lucrative opportunities for the market in the coming years. 

Market Segmentation 

The global helicobacter pylori test market is mainly classified based on type, technology, and end user. Type is further segmented into Endoscopic and Non-Endoscopic. By technology, the market is divided into Point-of-Care (POC), Immunoassays, and Molecular Diagnostics. By end user, the market is further divided into Hospital & Clinics, Diagnostic Center, and Others. 

Based on technology, Point-of-Care (POC) was dominating the global helicobacter pylori test market in 2019, owing to the rising investment in R&D processes to gain competitive advantage and offer distinguished solutions, and commercialization of Point-of-Care (POC) technology for helicobacter pylori testing. For instance, Exalenz Bioscience has introduced the new BreathID Hp Lab system. The BreathID Hp systems are intuitive and time-efficient products that detect active carcinogenic H. pylori bacterial infection. The point-of-care BreathID Hp Lab system provides an automated solution for batch test analysis. 

Regional Analysis 

Based on geography, the global helicobacter pylori test market is divided into North America, Europe, Asia-Pacific, South America, and Middle East & Africa. North America is further divided in the U.S., Canada, and Mexico, whereas Europe consists of the UK, Germany, France, Italy, and Rest of Europe. Asia-Pacific is segmented into India, China, Japan, South Korea, and Rest of Asia-Pacific. The South America region includes Brazil, Argentina, and the Rest of South America, while the Middle East & Africa is categorized into GCC Countries, Egypt, South Africa, and Rest of Middle East & Africa. 

Europe has shown significant growth in 2019, due to the commercialization of new technology for helicobacter pylori testing, the partnership between companies to develop helicobacter pylori testing device, and government organizations are taking initiatives to create awareness in public regarding H. Pylori infection. For instance, the Healthy Stomach Initiative (HSI) has conducted an awareness program to boost research about gastroenteritis, functional dyspepsia and gastric cancer. The awareness program was conducted to improve early detection, prevent its development, and extend survival. The development of gastric carcinogenesis is due to the infection with bacterium Helicobacter pylori. At least 90% of gastric cancer cases are related to H. pylori. The government body has several data showing that helicobacter pylori testing helps in early detection of gastric cancer. 

Competitive landscape 

Key players operating in the helicobacter pylori test industry include Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc., Abbott Laboratories, Cardinal Health, Bio-Rad Laboratories, Inc., QIAGEN, Quest Diagnostics Incorporated, Meridian Bioscience, CorisBioconcept SPRL, and Biohit Oyj. 

Increasing research studies on Helicobacter pylori test by the companies, rising awareness about helicobacter pylori test by the companies to increase their competitiveness in the market, the collaboration between companies to develop and market helicobacter pylori test, and commercialization of new helicobacter pylori test are some of the strategies adopted by the major companies. For instance, on August 21, 2018, TECHLAB, Inc., developer and manufacturer of rapid non-invasive diagnostic tests for gastrointestinal diseases, has received U.S. Food and Drug Administration (FDA) approval for the H. PYLORI QUIK CHEK and H. PYLORI CHEK tests. These tests are designed to aid in the diagnosis of H. pylori infection. The H. PYLORI QUIK CHEK test is a rapid diagnostic test that helps to detect H. pylori in 30 minutes. The H. PYLORI CHEK test is a 96-well plate format diagnostic for laboratories testing large numbers of specimens in one hour.  

Helicobacter Pylori Test Market Key Segments: 

By Type 

  • Endoscopic 
  • Non-Endoscopic 

By Technology 

  • Point-of-Care (POC) 
  • Immunoassays 
  • Molecular Diagnostics 

By End User 

  • Hospital & Clinics 
  • Diagnostic Center 
  • Others 

Key Global Helicobacter Pylori Test Industry Players 

  • Hoffmann-La Roche Ltd 
  • Thermo Fisher Scientific Inc. 
  • Abbott Laboratories 
  • Cardinal Health 
  • Bio-Rad Laboratories, Inc. 
  • QIAGEN 
  • Quest Diagnostics Incorporated 
  • Meridian Bioscience 
  • CorisBioconcept SPRL 
  • Biohit Oyj 

What Report Provides 

  • Full in-depth analysis of the parent Industry 
  • Important changes in market and its dynamics 
  • Segmentation details of the market 
  • Former, on-going, and projected market analysis in terms of volume and value 
  • Assessment of niche industry developments 
  • Market share analysis 
  • Key strategies of major players 
  • Emerging segments and regional growth potential 

1. Market Introduction
1.1. Executive Summary
1.2. Market Definition
1.3. Market Scope
2. Research Methodology
2.1. Primary Research
2.2. Research Methodology
2.3. Assumptions & Exclusions
2.4. Secondary data sources
3. Helicobacter Pylori Test Market Overview
3.1. Report Segmentation & Scope
3.2. Key Market Trend
3.3. Drivers
3.3.1. Rising Prevalence of Helicobacter Pylori
3.4. Restraints
3.4.1. Lack of Awareness Regarding Helicobacter Pylori Infection
3.5. Opportunity
3.5.1. Rising Demand of Point of Care Testing Devices for Helicobacter Pylori
3.6. Porter’s Five Forces Analysis
3.6.1. Porter’s Five Forces Analysis
3.7. Market Share Analysis
4. Type Overview
4.1. Introduction
4.1.1. Market Size & Forecast
4.2. Endoscopic
4.2.1. Market Size & Forecast
4.3. Non-Endoscopic
4.3.1. Market Size & Forecast
5. Technology Overview
5.1. Introduction
5.1.1. Market Size & Forecast
5.2. Point-of-Care (POC)
5.2.1. Market Size & Forecast
5.3. Immunoassays
5.3.1. Market Size & Forecast
5.4. Molecular Diagnostics
5.4.1. Market Size & Forecast
6. End User Overview
6.1. Introduction
6.1.1. Market Size & Forecast
6.2. Hospital & Clinics
6.2.1. Market Size & Forecast
6.3. Diagnostic Center
6.3.1. Market Size & Forecast
6.4. Others
6.4.1. Market Size & Forecast
7. Helicobacter Pylori Test Market Regional Overview
7.1. Introduction
7.1.1. Market Size & Forecast
7.2. North America Helicobacter Pylori Test Market
7.2.1. North America Market Size & Forecast, By Country
7.2.2. North America Market Size & Forecast, By Type
7.2.3. North America Market Size & Forecast, By Technology
7.2.4. North America Market Size & Forecast, By End User
7.2.5. U.S.
7.2.5.1. Market Size and Forecast
7.2.6. Canada
7.2.6.1. Market Size and Forecast
7.2.7. Mexico
7.2.7.1. Market Size and Forecast
7.3. Europe Helicobacter Pylori Test Market
7.3.1. Europe Market Size & Forecast, By Country
7.3.2. Europe Market Size & Forecast, By Type
7.3.3. Europe Market Size & Forecast, By Technology
7.3.4. Europe Market Size & Forecast, By End User
7.3.5. Germany
7.3.5.1. Market Size and Forecast
7.3.6. France
7.3.6.1. Market Size and Forecast
7.3.7. UK
7.3.7.1. Market Size and Forecast
7.3.8. Italy
7.3.8.1. Market Size and Forecast
7.3.9. Spain
7.3.9.1. Market Size and Forecast
7.3.10. Rest of Europe
7.3.10.1. Market Size and Forecast
7.4. Asia-Pacific Helicobacter Pylori Test Market
7.4.1. Asia-Pacific Market Size & Forecast, By Country
7.4.2. Asia-Pacific Market Size & Forecast, By Type
7.4.3. Asia-Pacific Market Size & Forecast, By Technology
7.4.4. Asia-Pacific Market Size & Forecast, By End User
7.4.5. Japan
7.4.5.1. Market Size and Forecast
7.4.6. China
7.4.6.1. Market Size and Forecast
7.4.7. Australia
7.4.7.1. Market Size and Forecast
7.4.8. India
7.4.8.1. Market Size and Forecast
7.4.9. South Korea
7.4.9.1. Market Size and Forecast
7.4.10. Rest of Asia-Pacific
7.4.10.1. Market Size and Forecast
7.5. South America Helicobacter Pylori Test Market
7.5.1. South America Market Size & Forecast, By Country
7.5.2. South America Market Size & Forecast, By Type
7.5.3. South America Market Size & Forecast, By Technology
7.5.4. South America Market Size & Forecast, By End User
7.5.5. Brazil
7.5.5.1. Market Size and Forecast
7.5.6. Argentina
7.5.6.1. Market Size and Forecast
7.5.7. Rest of South America
7.5.7.1. Market Size and Forecast
7.6. Middle East & Africa Helicobacter Pylori Test Market
7.6.1. Middle East & Africa Market Size & Forecast, By Country
7.6.2. Middle East & Africa Market Size & Forecast, By Type
7.6.3. Middle East & Africa Market Size & Forecast, By Technology
7.6.4. Middle East & Africa Market Size & Forecast, By End User
7.6.5. GCC Countries
7.6.5.1. Market Size and Forecast
7.6.6. Egypt
7.6.6.1. Market Size and Forecast
7.6.7. South Africa
7.6.7.1. Market Size and Forecast
7.6.8. Rest of Middle East & Africa
7.6.8.1. Market Size and Forecast
8. Company Profile
8.1. Hoffmann-La Roche Ltd
8.1.1. Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
8.1.2. Hoffmann-La Roche Ltd Product Category, Application, and Specification
8.1.3. Hoffmann-La Roche Ltd Financial Performance (2016-2018)
8.1.4. Main Business/Business Overview
8.2. Thermo Fisher Scientific Inc.
8.3. Abbott Laboratories
8.4. Cardinal Health
8.5. Bio-Rad Laboratories, Inc.
8.6. QIAGEN
8.7. Quest Diagnostics Incorporated
8.8. Meridian Bioscience
8.9. CorisBioconcept SPRL
8.10. Biohit Oyj

  • Hoffmann-La Roche Ltd 
  • Thermo Fisher Scientific Inc. 
  • Abbott Laboratories 
  • Cardinal Health 
  • Bio-Rad Laboratories, Inc. 
  • QIAGEN 
  • Quest Diagnostics Incorporated 
  • Meridian Bioscience 
  • CorisBioconcept SPRL 
  • Biohit Oyj 

n/a

Frequently Asked Questions